Today Apiject Systems, Corp. (Apiject, announced its submission for regulatory approval of its New Drug Application (NDA) to ...
A tragic RSV vaccine trial in the 1960s set the field back for decades. Here’s how scientists finally made breakthroughs in ...
The ready-to-use pharmaceutical packaging market is poised for growth due to a rising demand for efficient drug packaging ...
The FDA approved a supplemental new drug application for Tremfya for the treatment of children aged 6 years or older with ...
When Laura Ehrlich gave birth to her first child in 2020, the COVID-causing virus wasn’t the only threat facing her son. Born ...
ARTIOS Phase IIIb, open-label, single-arm, prospective study showed a substantial reduction in disease activity in people with relapsing multiple sclerosis (RMS) following switch to Kesimpta after ...
Indian drugmakers Eris Lifesciences, Wockhardt and Lupin are prepping to cash in when Danish company Novo Nordisk bows out of ...
Anifrolumab, a type I interferon receptor antagonist, is currently approved under the brand name Saphnelo for IV administration in the treatment of moderate to severe SLE.
Hidradenitis suppurativa (HS) may affect 1 in 100 people. Lily is now speaking up so no one else has to suffer in silence.
Mahmoud is one of more than 167,000 people to have been reported injured in Gaza since 7 October 2023, according to the Gaza ...
Bank of America Global Healthcare Conference 2025 September 24, 2025 5:45 AM EDTCompany ParticipantsMarco Dal Lago ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback